Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01117415 · ClinicalTrials.gov registry record
Cost Effectiveness Analysis of Cholecystectomy, Projected Long Term Outcomes and Complications Evaluation
A clinical trial of Cholelithiasis, sponsored by University Hospitals Cleveland Medical Center.
- Completed
- Registry status
- 37
- Enrollment target
- 1
- Study location
NCT01117415: Completed study of Cholelithiasis, sponsored by University Hospitals Cleveland Medical Center.
NCT01117415 is a study of Cholelithiasis that has completed, run by University Hospitals Cleveland Medical Center. The registered enrollment target is 37 participants, below the 237-participant average among 3 other Cholelithiasis trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01117415, a study of Cholelithiasis, has completed, sponsored by University Hospitals Cleveland Medical Center.
- COMPLETED
- Registry status
- 37 participants
- Enrollment target
- 1
- Study location
Study Summary
Participation in this research study does not involve any procedures. Health preference will be ascertained through standard techniques including time-tradeoff, standard gamble, and rating scale to assess risks regarding potential complications specific to NOTES (Natural Orifice Translumenal Endoscopic Surgery)gallbladder removal.
Primary Outcome
One year cost effectiveness data comparing transgastric cholecystectomy, transvaginal cholecystectomy, and laparoscopic cholecystectomy. Costs from two national databases: the State Ambulatory Surgery Database (SASD) and the NIS. The main outcome measure for this study will be cost per quality adjusted life year (QALY). Markov modeling techniques for model patient experiences for each of the procedures analyzed. Monte Carlo simulation will be used to calculate cost per QALY over a one year time
Conditions Studied
Study Locations (1)
Ohio
- University Hospitals Case Medical Center - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 37 participants |
| Start Date | 2007-04 |
| Est. Completion | 2010-06 |
What the finished NCT01117415 record still lists
NCT01117415 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 37 participants, a relatively small participant target, below the 237-participant average among 3 other Cholelithiasis trials with a reported enrollment target (84% lower).
The record links to 1 condition, with Cholelithiasis appearing as the primary indexed condition, and to 0 interventions.
NCT01117415 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT01117415 about?
NCT01117415 is a clinical study titled "Cost Effectiveness Analysis of Cholecystectomy, Projected Long Term Outcomes and Complications Evaluation". Participation in this research study does not involve any procedures. Health preference will be ascertained through standard techniques including time-tradeoff, standard gamble, and rating scale to assess risks regarding potential complications specific to NOTES (Natural Orifice Translumenal Endosco...
What is the current status of trial NCT01117415?
This trial is currently completed. The enrollment target is 37 participants. The study started on 2007-04. Estimated completion is 2010-06.
What conditions does trial NCT01117415 study?
This clinical trial studies the following conditions: Cholelithiasis.
Who is sponsoring clinical trial NCT01117415?
This trial is sponsored by University Hospitals Cleveland Medical Center, which has 230 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01117415 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cholelithiasis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02800486 · 37 participants · Phase 2
Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA
- NCT03173937 · 37 participants · Phase 1
Unrelated Umbilical Cord Blood Transplantation for Severe Aplastic Anemia and Hypo-plastic MDS Using CordIn(TM), Umbilical Cord Blood-Derived Ex Vivo Expanded Stem and Progenitor Cells to Expedite Engraftment and Improve Transplant Outcome
- NCT03295227 · 37 participants · Phase 1
Pembrolizumab in Treating Participants With Unresectable Thymoma or Thymic Cancer
- NCT03401047 · 37 participants · Early Phase 1
Study to Assess Potential Impairments in Estradiol Augmentation of Gonadotropin Secretion in Polycystic Ovary Syndrome
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia